Please select your organization type / ????????????:
Partnering landscape in China: Going global
2011 was the most active year yet in China's short history of pharma partnering. Pharma executives discuss deals they've done in cross-border partnering with China.
Venture capital and private equity landscape in China
VCs in China run the gamut from traditional firms to government-supported funds to corporate funds; our VC panelists are all actively investing in China pharma and biotech.
How to find and identify early stage science in China
China is becoming a center of global innovation. What drives this increase in novel technology development? Panelists who are actively driving innovation in China have answers.
The road to China: A fireside chat
The road to China can take many paths. Our Fireside Chat features two industry leaders who have embarked on the adventure, sharing their dos and don'ts of coming to China.
Regional focus: Leveraging commercial rights for the China market
This panel examines strategies to penetrate the China market such as building up a new presence in China or making commercialization deals with established Chinese companies.
? 1100 scheduled one-to-one meetings
Copyright © 2017, ChinaBio® LLC - ChinaBio is a registered trademark of ChinaBio® LLC